GW604714X

Cat. No. M56715

All AbMole products are for research use only, cannot be used for human consumption.

Size	Price	Availability
1mg	USD 50	In stock
5mg	USD 100	In stock
10mg	USD 150	In stock

Free Delivery on orders over USD 500 Bulk Inquiry?

GW604714X is a potent inhibitor of mitochondrial respiration supported by pyruvate but not other substrates.

Molecular Weight	471.46
Formula	C21H18FN5O5S
CAS Number	853953-65-8
Form	Solid
Solubility (25°C)	DMF 5 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Mitochondrial Related Products
Thiabendazole Thiabendazole inhibites the mitochondrial helminth-specific enzyme, fumarate reductase, with anthelminthic property.
VLX600 VLX600 is a novel inhibitor of iron-chelated oxidative phosphorylation (OXPHOS). VLX600 causes mitochondrial dysfunction and can show enhanced cytotoxicity in nutrient deficiency conditions. VLX600 showed selective cytotoxic activity against malignant cells and induced autophagy and had anticancer activity.*The compound is unstable in solutions, freshly prepared is recommended
FCCP FCCP is a mitochondrial uncoupling agent and an oxidative phosphorylation (OXPHOS) inhibitor. FCCP is often used as an apoptosis inducer.
Lixumistat Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat (IM156) is a metformin derivative, which increases AMPK phosphorylation.
KL1333 KL1333 is an orally available, small organic molecule that reacts with NAD(P)H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation.

Catalog